LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Nov 10, 2023
Product Development
NorthSea pivots to diabetic NASH patients on Phase IIb icosabutate data
Misses primary non-alcoholic steatohepatitis resolution endpoint in all comers, but hits in Type II diabetes subgroup
Read More
BioCentury
|
Aug 10, 2023
Product Development
Obesity mechanisms in the clinic: which overlap, and which branch out
Like incretins, most clinical programs modulate glucose homeostasis and appetite, but a few work in new ways that could be more selective for fat loss
Read More
BioCentury
|
Mar 29, 2023
Product Development
Next up in obesity therapeutics
Late-stage pipeline dominated by large pharmas, GLP-1 combinations
Read More
BioCentury
|
Oct 25, 2018
Distillery Therapeutics
Neurology
Read More
BioCentury
|
Apr 13, 2018
Company News
Tasly gets Chinese rights to Lilly's diabetes candidate
Read More
BioCentury
|
Sep 14, 2017
Strategy
Numerate’s Intelligence
How Numerate’s AI tackles translational questions with tiny data sets
Read More
BioCentury
|
Feb 2, 2017
Distillery Therapeutics
Endocrine / Metabolic
Read More
BioCentury
|
Dec 4, 2014
Cover Story
GPCRs' grand plans
Read More
BioCentury
|
Oct 13, 2014
Strategy
Streamlining Takeda's Profit Story
Takeda needs to execute on cost-cutting, pipeline to meet EPS expectations
Read More
BioCentury
|
Aug 14, 2014
Distillery Therapeutics
Indication: Endocrine/metabolic disease
Read More
Items per page:
10
1 - 10 of 29
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help